SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037722
Filing Date
2020-08-06
Accepted
2020-08-06 16:06:58
Documents
68
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q - Q2/2020 ctmx-10q_20200630.htm   iXBRL 10-Q 2975540
2 EX-4.4 DESCRIPTION OF SECURITIES 6-30-20 ctmx-ex44_216.htm EX-4.4 47200
3 EX-31.1 ctmx-ex311_16.htm EX-31.1 19579
4 EX-31.2 ctmx-ex312_15.htm EX-31.2 19591
5 EX-32.1 ctmx-ex321_14.htm EX-32.1 10161
6 EX-32.2 ctmx-ex322_13.htm EX-32.2 10483
  Complete submission text file 0001564590-20-037722.txt   9186713

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ctmx-20200630.xsd EX-101.SCH 60899
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctmx-20200630_cal.xml EX-101.CAL 49012
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctmx-20200630_def.xml EX-101.DEF 226435
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctmx-20200630_lab.xml EX-101.LAB 403574
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctmx-20200630_pre.xml EX-101.PRE 359822
12 EXTRACTED XBRL INSTANCE DOCUMENT ctmx-10q_20200630_htm.xml XML 1541729
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 201081597
SIC: 2834 Pharmaceutical Preparations